Bolt Biotherapeutics
5 followers
Bolt Biotherapeutics, Inc., based in the San Francisco Bay Area, is a publicly-traded biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISAC), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical stu... Read more
Org chart
Randall Schatzman
CEO & Board Member
Randall Schatzman
Collapse
Willie Quinn
President & CEO
Grant Yonehiro
Chief Business Officer
Michael N. Alonso
VP, Immunology & Pharmacology
Nathan Ihle
VP, CMC & Quality
Wesley Burwell
VP, Head of HR
Sarah Nemec
VP, Finance & Principal Accounting Officer
Lu Xu
VP, Developmental Science
Pam Howland
VP, Portfolio & Program Management
Lynn Ferguson Lewis
Head Of Information Technology
Dawn Colburn
SVP, Clinical Development
Coya Tapia
Medical Director
Arthur Lee
Principal Scientist
Husein Hadeiba
Senior Scientist
Kristi Balacy
Director Clinical Operations
Lindsey Gourley
Sr. Clinical Trial Manager
Jenny Yuan
Director, Head Of Statistical Programming
Jason Ptacek
Director Of Translational Science And Biomarkers
Samara Violet
Director Project Management
Murray Nguyen
Senior Lab Operations Manager
Anthony Wong
QC Manager
Christine Gustin
Manager Of Biosample Operations
